Viewing Study NCT06149169


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2025-12-25 @ 8:24 PM
Study NCT ID: NCT06149169
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-08-21
First Post: 2023-11-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma
Sponsor: Shanghai Ming Ju Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module